Executive Summary

HSBC Holdings plc (LSE:HSBA) on 14 April 2026 released an Overseas Regulatory Announcement to the Regulatory News Service of the London Stock Exchange, mirroring an announcement first released to The Stock Exchange of Hong Kong Limited under rules 17.06A, 17.06B and 17.06C of the Hong Kong Listing Rules. The announcement reports the grant on 13 April 2026 of conditional awards to employees, entitling them to subscribe for 307,754.79576 ordinary shares of US$0.50 each in the Company under the HSBC International Employee Share Purchase Plan. The grant was split between 160,942.19905 LSE-listed shares and 146,812.59671 HKSE-listed shares, with no purchase price payable by the recipients and a vesting period of two years and six months from the grant date.

The announcement also confirms that, as the Plan is an all-employee arrangement, no performance conditions or clawback provisions apply, and that no financial assistance is being provided by the Company or any subsidiary to grantees in connection with the Awards. The disclosure is signed by Angela McEntee, Group Company Secretary, and is accompanied by the standard list of the directors of HSBC Holdings plc as constituted at the date of the announcement, in line with the Hong Kong Listing Rule requirement that announcements include details of the issuer's board composition for the benefit of Hong Kong investors.

Background: The HSBC International Employee Share Purchase Plan

The HSBC International Employee Share Purchase Plan is a globally administered all-employee share scheme that allows eligible HSBC Group employees in many jurisdictions to acquire ordinary shares in HSBC Holdings plc on advantageous terms. Such plans, often called employee share purchase plans or share matching plans depending on their structure, are a long-established feature of compensation at internationally listed banks. They are designed to align employees' financial interests with those of long-term shareholders, support staff retention by tying realisation of value to a future vesting date, and encourage broad ownership across all levels of the workforce rather than only at executive level.

Conditional awards under such plans typically take the form of a contractual right to receive shares at a future date provided the employee remains in service through the vesting period and complies with the rules of the plan. The 'conditional' element means that the employee does not yet own the shares and is not entitled to dividends or voting rights until the awards vest. Where, as here, the purchase price payable on vesting is GBP 0, the awards behave economically like restricted stock units rather than option-style instruments.

HSBC, as a dual primary listed company on the London and Hong Kong stock exchanges, calibrates its all-employee plans so that grantees in different jurisdictions can hold shares listed on the relevant exchange most appropriate to their location. The split between 160,942.19905 LSE-listed shares and 146,812.59671 HKSE-listed shares in this grant reflects the geographical distribution of grantees, with a slight tilt towards the LSE line that may indicate marginally higher participation among employees based in the United Kingdom and other Europe, Middle East and Africa locations relative to the Asia Pacific region.

Why a Hong Kong Listing Rule Filing?

HSBC Holdings plc is listed on the Main Market of the London Stock Exchange and is also a primary listed issuer on The Stock Exchange of Hong Kong Limited. As a result, the Company is subject simultaneously to the Listing Rules of both exchanges and to the disclosure regimes of both the Financial Conduct Authority and the Hong Kong Securities and Futures Commission. Rules 17.06A, 17.06B and 17.06C of the Hong Kong Listing Rules require an issuer that has granted options, warrants or other share-based awards to publish an announcement on the day of grant or the next business day, setting out specified information including the grant date, category of grantee, number of underlying shares, market price on the grant date, exercise or purchase price, vesting period, performance conditions and clawback provisions, any financial assistance arrangements, and the number of shares available for future grant under the plan mandate.

Because the original announcement was published in Hong Kong, HSBC is also obliged under London's continuing obligations regime to make the same information available to investors in the United Kingdom on a non-discriminatory basis, which is achieved through an 'Overseas Regulatory Announcement' issued to RNS. This is the function of the present filing: it places UK and other RNS-subscribed investors on the same informational footing as Hong Kong holders.

Rule 17.06C in particular addresses the scheme mandate limit. Plans of this type are subject to a 10 per cent limit on the number of shares that can be committed for issuance, calculated by reference to the issued ordinary share capital of the Company and inclusive of awards under all share plans operated by the Company over the previous ten years. The announcement notes that, after this grant, the number of shares available for issue under that limit is 1,108,840,359, which is a significant headroom indicating that HSBC retains substantial flexibility to make further awards under its various plans.

Quantitative Detail of the Grant

The grant date is 13 April 2026. The category of grantee is recorded simply as 'Employees', reflecting the all-employee nature of the Plan. The number of shares under Awards is 307,754.79576 ordinary shares of US$0.50 nominal value, with a fractional element arising from the per-employee accumulation methodology typical of monthly contribution share purchase schemes. The split between LSE and HKSE listings is 160,942.19905 and 146,812.59671 shares respectively, broadly a 52:48 ratio in favour of the London line.

The closing market price of HSBC Holdings ordinary shares on the date of grant was GBP 13.324 on the London Stock Exchange and HKD 138.80 on The Stock Exchange of Hong Kong. At those reference prices, the gross face value of the LSE-listed tranche is approximately GBP 2.144 million and the HKSE-listed tranche is approximately HKD 20.38 million, giving a combined notional value of roughly USD 5.4 million using the implicit cross at the time of grant. This is a small but meaningful charge that will be expensed over the vesting period in the Group's income statement.

The purchase price of the Awards is GBP 0, confirming the restricted-share-style economics of the grants. The vesting period is two years and six months, a duration that is at the longer end for all-employee schemes but consistent with HSBC's preference for retention through the cycle. Grants do not have performance conditions or clawback provisions: this is a deliberate design feature, reflecting the principle that all-employee plans should be inclusive and accessible rather than predicated on individual performance.

Governance and Board Composition

The announcement also republishes the composition of the HSBC Board of Directors as at the date of issue. The directors comprise Brendan Robert Nelson as Independent non-executive Chairman; Georges Bahjat Elhedery as Group Chief Executive (executive director); Manveen 'Pam' Kaur as Group Chief Financial Officer (executive director); and a slate of independent non-executive directors comprising Geraldine Joyce Buckingham, Wei Sun Christianson, Rachel Duan, Dame Carolyn Julie Fairbairn, James Anthony Forese, Ann Frances Godbehere, Steven Craig Guggenheimer, Dr José Antonio Meade Kuribrena, Kalpana Jaisingh Morparia, Eileen K Murray and Swee Lian Teo.

Including the board composition in the announcement is a Hong Kong Listing Rule requirement for listed issuers and is a feature unique to HSBC's Asia-listed obligations. The disclosure therefore serves two purposes simultaneously: it provides the technical detail of the share grant in compliance with the rules governing equity-settled employee compensation, and it gives Hong Kong holders comfort that the Board roster is current at the date of issuance.

Financial Reporting and Dilution Implications

The accounting treatment of the Awards is governed by IFRS 2, Share-based Payment. As the Awards are equity-settled and have no performance conditions, the fair value at grant date will be recognised in employee compensation expense on a straight-line basis over the two-and-a-half-year vesting period, with a corresponding credit to equity. The fair value at grant date is determined by reference to the closing share price on the grant date adjusted for expected dividends foregone over the vesting period.

From a dilution perspective, the grant of just over 307,000 shares is immaterial relative to HSBC's issued ordinary share capital, which exceeds 18 billion shares. The Company's share buy-back programmes routinely retire substantially more shares than are issued under employee share plans, with the result that net dilution is minimal and the broader implications for earnings per share, return on tangible equity and the Group's regulatory capital ratios are negligible. The strategic significance of the grant is therefore not its quantum but the consistency it signals: HSBC continues to operate broad-based ownership programmes across its global workforce as a matter of standing policy.

Conclusion

The Overseas Regulatory Announcement of 14 April 2026 reports a routine but important annual cycle event in HSBC's compensation calendar: the issue of conditional awards under its International Employee Share Purchase Plan. While modest in absolute size, the disclosure is procedurally required under both Hong Kong and UK rules, ensures parity of information between investors in the two markets, and confirms that the Group continues to operate its all-employee share plan within established mandate limits. For shareholders, the announcement provides a useful data point on the cost and structure of HSBC's employee equity programmes, and reinforces the Group's commitment to inclusive ownership without compromising on shareholder protections through preserved dilution headroom and disciplined plan administration.

Operational and Talent Considerations

Beyond the technical disclosure framework, the HSBC International Employee Share Purchase Plan plays an important role in the Group's broader talent management and employee engagement strategy. All-employee share schemes provide a tangible, financial expression of the principle that employees are stakeholders in the long-term success of the business, and they typically generate measurable improvements in retention, engagement and the cultural alignment of staff with shareholder interests. For a global group such as HSBC with employees in dozens of jurisdictions, the operational complexity of running such a scheme is considerable and requires close coordination between human resources, treasury, legal, tax and company secretarial teams.

The grant cycle itself is also a useful indicator of the Group's compensation calendar. April grants under the International Employee Share Purchase Plan typically follow the close of the financial year, the publication of annual results and the release of the Group's annual report, and they coincide with the broader cycle of bonus awards, executive equity grants under the Group's performance share plan and other compensation events. Observers tracking the timing of these events build a useful picture of the rhythm of the Group's compensation framework and of the quantum of equity-settled compensation flowing into the global employee base each year.

From the perspective of the Hong Kong market, the parallel filing under the Hong Kong Listing Rules also reflects the unique position of HSBC as one of the most prominent dual primary listed financial institutions in the world. The Hong Kong listing has historically been the largest by market capitalisation traded outside of the United Kingdom, and the regulatory disclosure regime in Hong Kong is arguably more prescriptive about share-based compensation announcements than the equivalent UK regime. The discipline of meeting both sets of requirements simultaneously and consistently is a hallmark of the Group's compliance posture and of its long-standing commitment to keeping investors in both jurisdictions equally well informed.